公司資料
Greenwich LifeSciences 股價、新聞與催化劑
- 股票代碼:
- GLSI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
18.39 USD (+17.66%)
收盤價
最後更新: 2026年9月17日
357M USD
市值
股價為何變動
截至 2026年9月17日，GLSI 上漲 17.7%，收於 $18.39。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Greenwich LifeSciences is an immunotherapy company focused on cancer vaccines and breast-cancer treatment. Its story is built around a narrow but potentially differentiated oncology program.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Greenwich sits in specialty oncology biotechnology.
商業模式特徵
The company depends on clinical data, target validation, and the possibility of creating a focused cancer-immunotherapy franchise.
生技產業定位
Greenwich is a high-catalyst oncology name whose stock is very sensitive to trial and translational outcomes.
未來催化劑
- Greenwich’s catalysts are its breast-cancer immunotherapy program and any update that shows the platform still has a path forward. The next development step matters because the story is still highly data-dependent.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。